SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (891)1/15/2004 8:20:07 PM
From: Biotech Jim  Read Replies (1) | Respond to of 1005
 
It's clear from the article you posted that they do not know or understand the mechanism of action of Gabapentin. C. Taylor (now Pfizer, from Warner Lambert) has provided some guiding light on it working via N-type calcium channels. Makes me wonder about some of their other work?

BJ